S&C
Stephens & Co. Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
301
Azenta
AZTA
$1.34B
|
JJ
Jacob Johnson
| $29.28 | $60 |
105%
upside
| Overweight |
2 Jan ‘25
8 months ago |
|
302
Alignment Healthcare
ALHC
$3.26B
|
SF
Scott Fidel
| $16.45 | $17 |
3%
upside
| Overweight |
2 Jan ‘25
8 months ago |
|
303
Castle Biosciences
CSTL
$665M
|
MC
Mason Carrico
| $22.94 | $41 |
79%
upside
| Overweight |
2 Jan ‘25
8 months ago |
|
304
PROG Holdings
PRG
$1.39B
|
KJ
Kyle Joseph
| $35.05 | $60 |
71%
upside
| Overweight |
2 Jan ‘25
8 months ago |
|
305
Valley National Bancorp
VLY
$5.99B
|
MB
Matt Breese
| $10.71 | $12.50 |
17%
upside
| Overweight |
2 Jan ‘25
8 months ago |
|
|
STKL
306
SunOpta
STKL
$735M
|
JS
Jim Salera
| $6.22 | $10 |
61%
upside
| Overweight |
2 Jan ‘25
8 months ago |
|
307
Definitive Healthcare
DH
$414M
|
JG
Jeff Garro
| $3.98 | $5 |
26%
upside
| Equal-Weight |
20 Dec ‘24
8 months ago |
|
308
Doximity
DOCS
$12.9B
|
JG
Jeff Garro
| $69 | $55 |
20%
downside
| Equal-Weight |
20 Dec ‘24
8 months ago |
|
309
OptimizeRx
OPRX
$326M
|
JG
Jeff Garro
| $17.56 | $5.50 |
69%
downside
| Equal-Weight |
20 Dec ‘24
8 months ago |
|
310
IQVIA
IQV
$31.3B
|
JG
Jeff Garro
| $183.87 | $250 |
36%
upside
| Overweight |
20 Dec ‘24
8 months ago |
|
311
Centene
CNC
$15.4B
|
SF
Scott Fidel
| $31.27 | $73 |
133%
upside
| Equal-Weight |
13 Dec ‘24
9 months ago |
|
312
UnitedHealth
UNH
$314B
|
SF
Scott Fidel
| $346.78 | $675 |
95%
upside
| Overweight |
5 Dec ‘24
9 months ago |
|
313
Plumas Bancorp
PLBC
$313M
|
AT
Andrew Terrell
| $45.10 | $60 |
33%
upside
| Overweight |
27 Nov ‘24
9 months ago |
|
314
First Hawaiian
FHB
$3.19B
|
AT
Andrew Terrell
| $25.57 | $30 |
17%
upside
| Equal-Weight |
27 Nov ‘24
9 months ago |
|
315
Actinium Pharmaceuticals
ATNM
$50.2M
|
SL
Sudan Loganathan
| $1.61 | $5 |
211%
upside
| Overweight |
19 Nov ‘24
9 months ago |
|
316
C4 Therapeutics
CCCC
$188M
|
SL
Sudan Loganathan
| $2.64 | $4 |
52%
upside
| Equal-Weight |
18 Nov ‘24
9 months ago |
|
317
Arvinas
ARVN
$575M
|
SL
Sudan Loganathan
| $7.83 | $55 |
602%
upside
| Overweight |
18 Nov ‘24
9 months ago |
|
318
PACS Group
PACS
$1.2B
|
SF
Scott Fidel
| $7.71 | $31 |
302%
upside
| Overweight |
18 Nov ‘24
9 months ago |
|
319
Upbound Group
UPBD
$1.46B
|
KJ
Kyle Joseph
| $25.17 | $38 |
51%
upside
| Overweight |
13 Nov ‘24
10 months ago |
|
320
Regional Management Corp
RM
$412M
|
KJ
Kyle Joseph
| $42.08 | $30 |
29%
downside
| Equal-Weight |
13 Nov ‘24
10 months ago |
|
321
Enova International
ENVA
$2.88B
|
VC
Vincent Caintic
| $115.27 | $108 |
6%
downside
| Overweight |
13 Nov ‘24
10 months ago |
|
322
Atlanticus Holdings
ATLC
$1.02B
|
KJ
Kyle Joseph
| $67.14 | $54 |
20%
downside
| Overweight |
13 Nov ‘24
10 months ago |
|
323
Pyxis Oncology
PYXS
$116M
|
SL
Sudan Loganathan
| $1.87 | $13 |
595%
upside
| Overweight |
8 Nov ‘24
10 months ago |
|
324
Jack Henry & Associates
JKHY
$11.6B
|
CN
Charles Nabhan
| $159.10 | $170 |
7%
upside
| Equal-Weight |
6 Nov ‘24
10 months ago |
|
325
Coterra Energy
CTRA
$18.6B
|
MS
Mike Scialla
| $24.37 | $29 |
19%
upside
| Overweight |
1 Nov ‘24
10 months ago |
|